| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
|
J Clin Oncol
|
2011
|
7.65
|
|
2
|
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.
|
Lancet
|
2011
|
4.79
|
|
3
|
Genetic testing in pheochromocytoma or functional paraganglioma.
|
J Clin Oncol
|
2005
|
3.20
|
|
4
|
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.
|
J Clin Oncol
|
2009
|
3.18
|
|
5
|
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.
|
Neuroendocrinology
|
2012
|
3.00
|
|
6
|
Combination chemotherapy in advanced adrenocortical carcinoma.
|
N Engl J Med
|
2012
|
2.82
|
|
7
|
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.
|
Eur J Hum Genet
|
2007
|
2.64
|
|
8
|
Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma.
|
Ann Surg
|
2012
|
2.35
|
|
9
|
Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
|
J Clin Endocrinol Metab
|
2008
|
2.30
|
|
10
|
Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.
|
Eur J Endocrinol
|
2008
|
2.23
|
|
11
|
Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.
|
J Clin Endocrinol Metab
|
2007
|
2.06
|
|
12
|
Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy.
|
J Clin Endocrinol Metab
|
2004
|
1.91
|
|
13
|
New therapeutic approaches to treat medullary thyroid carcinoma.
|
Nat Clin Pract Endocrinol Metab
|
2008
|
1.76
|
|
14
|
Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer.
|
J Clin Endocrinol Metab
|
2007
|
1.72
|
|
15
|
Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.
|
J Clin Endocrinol Metab
|
2005
|
1.64
|
|
16
|
Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas.
|
Surgery
|
2005
|
1.51
|
|
17
|
Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors.
|
Eur Radiol
|
2002
|
1.51
|
|
18
|
Medullary thyroid carcinoma.
|
Clin Endocrinol (Oxf)
|
2004
|
1.42
|
|
19
|
Gastroenteropancreatic high-grade neuroendocrine carcinoma.
|
Cancer
|
2014
|
1.32
|
|
20
|
Are G3 ENETS neuroendocrine neoplasms heterogeneous?
|
Endocr Relat Cancer
|
2013
|
1.31
|
|
21
|
Prognostic parameters of metastatic adrenocortical carcinoma.
|
J Clin Endocrinol Metab
|
2006
|
1.30
|
|
22
|
Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
|
Am J Gastroenterol
|
2006
|
1.19
|
|
23
|
Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.
|
Curr Oncol Rep
|
2013
|
1.19
|
|
24
|
Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
|
J Clin Oncol
|
2005
|
1.18
|
|
25
|
Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
|
J Clin Endocrinol Metab
|
2003
|
1.17
|
|
26
|
Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
|
J Vasc Interv Radiol
|
2008
|
1.17
|
|
27
|
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
|
J Clin Endocrinol Metab
|
2007
|
1.16
|
|
28
|
Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.15
|
|
29
|
Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma.
|
Thyroid
|
2002
|
1.13
|
|
30
|
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.
|
J Clin Endocrinol Metab
|
2012
|
1.11
|
|
31
|
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
|
J Clin Endocrinol Metab
|
2015
|
1.07
|
|
32
|
MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques.
|
AJR Am J Roentgenol
|
2003
|
1.07
|
|
33
|
Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study.
|
J Clin Endocrinol Metab
|
2013
|
1.05
|
|
34
|
Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
|
Surgery
|
2003
|
1.05
|
|
35
|
Hepatic metastases from neuroendocrine tumors with a "thin slice" pathological examination: they are many more than you think...
|
Ann Surg
|
2010
|
1.02
|
|
36
|
Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel.
|
J Clin Oncol
|
2010
|
1.02
|
|
37
|
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma.
|
Endocr Relat Cancer
|
2009
|
1.01
|
|
38
|
Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
|
J Clin Endocrinol Metab
|
2011
|
1.01
|
|
39
|
Ectopic ACTH syndrome in children and adolescents.
|
J Clin Endocrinol Metab
|
2011
|
1.01
|
|
40
|
Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads.
|
J Hepatol
|
2011
|
0.98
|
|
41
|
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.
|
Eur J Endocrinol
|
2013
|
0.97
|
|
42
|
Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma.
|
Eur J Endocrinol
|
2011
|
0.95
|
|
43
|
A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib.
|
Arch Dermatol
|
2012
|
0.94
|
|
44
|
Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma.
|
Eur J Endocrinol
|
2010
|
0.93
|
|
45
|
Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007.
|
J Thorac Oncol
|
2008
|
0.92
|
|
46
|
18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.91
|
|
47
|
Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
|
Thyroid
|
2012
|
0.91
|
|
48
|
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
|
Int J Cancer
|
2014
|
0.90
|
|
49
|
Charcoal suspension tattoo localization for differentiated thyroid cancer recurrence.
|
Ann Surg Oncol
|
2009
|
0.89
|
|
50
|
Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer.
|
J Clin Endocrinol Metab
|
2011
|
0.89
|
|
51
|
Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features.
|
Cancer
|
2007
|
0.88
|
|
52
|
High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up.
|
Eur J Endocrinol
|
2011
|
0.88
|
|
53
|
Clinical review: Current concepts in the management of unilateral recurrent laryngeal nerve paralysis after thyroid surgery.
|
J Clin Endocrinol Metab
|
2005
|
0.87
|
|
54
|
Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: screening for false positives and a prospective follow-up study.
|
Int J Biol Markers
|
2011
|
0.86
|
|
55
|
Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study.
|
J Clin Endocrinol Metab
|
2011
|
0.86
|
|
56
|
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.
|
Eur J Endocrinol
|
2014
|
0.85
|
|
57
|
Mitotane has an estrogenic effect on sex hormone-binding globulin and corticosteroid-binding globulin in humans.
|
J Clin Endocrinol Metab
|
2006
|
0.85
|
|
58
|
Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features.
|
Pancreas
|
2008
|
0.85
|
|
59
|
Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).
|
World J Surg
|
2009
|
0.84
|
|
60
|
One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma.
|
J Clin Endocrinol Metab
|
2013
|
0.84
|
|
61
|
FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma.
|
Horm Cancer
|
2011
|
0.84
|
|
62
|
Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels.
|
Thyroid
|
2012
|
0.84
|
|
63
|
Radioiodine therapy for papillary and follicular thyroid carcinoma.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.84
|
|
64
|
Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma.
|
Clin Endocrinol (Oxf)
|
2002
|
0.83
|
|
65
|
Molecular screening for a personalized treatment approach in advanced adrenocortical cancer.
|
J Clin Endocrinol Metab
|
2013
|
0.83
|
|
66
|
Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804.
|
J Clin Endocrinol Metab
|
2002
|
0.83
|
|
67
|
Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study.
|
Dig Liver Dis
|
2011
|
0.82
|
|
68
|
Mutational status of EGFR, BRAF, PI3KCA and JAK2 genes in endocrine tumors.
|
Int J Cancer
|
2009
|
0.81
|
|
69
|
Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1.
|
Dig Liver Dis
|
2011
|
0.81
|
|
70
|
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor.
|
Cardiovasc Intervent Radiol
|
2014
|
0.81
|
|
71
|
Inheritable forms of medullary thyroid carcinoma.
|
Biochimie
|
2002
|
0.81
|
|
72
|
Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma.
|
Head Neck
|
2011
|
0.81
|
|
73
|
Differential expression of galectin-3 in medullary thyroid carcinoma and C-cell hyperplasia.
|
Clin Endocrinol (Oxf)
|
2002
|
0.81
|
|
74
|
Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells.
|
Endocr Relat Cancer
|
2013
|
0.80
|
|
75
|
Resection margins and prognosis in locally invasive thyroid cancer.
|
Head Neck
|
2013
|
0.80
|
|
76
|
Carcinoma of endocrine organs: results of the RARECARE project.
|
Eur J Cancer
|
2012
|
0.80
|
|
77
|
Kinase inhibitors for advanced medullary thyroid carcinoma.
|
Clinics (Sao Paulo)
|
2012
|
0.80
|
|
78
|
Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
|
Clin Endocrinol (Oxf)
|
2005
|
0.80
|
|
79
|
Adrenocortical tumors: improving the practice of the Weiss system through virtual microscopy: a National Program of the French Network INCa-COMETE.
|
Am J Surg Pathol
|
2012
|
0.80
|
|
80
|
Transcatheter arterial chemoembolization for liver metastases in patients with adrenocortical carcinoma.
|
J Vasc Interv Radiol
|
2010
|
0.79
|
|
81
|
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
|
Hum Mol Genet
|
2013
|
0.79
|
|
82
|
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
|
Thyroid
|
2015
|
0.78
|
|
83
|
Thyroid cancer patients treated with 131I: radiation dose to relatives after discharge from the hospital.
|
Thyroid
|
2011
|
0.78
|
|
84
|
Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging.
|
J Clin Endocrinol Metab
|
2010
|
0.78
|
|
85
|
Preoperative localization of neck recurrences from thyroid cancer: charcoal tattooing under ultrasound guidance.
|
Thyroid
|
2015
|
0.77
|
|
86
|
Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma.
|
Endocr Relat Cancer
|
2010
|
0.77
|
|
87
|
[Treatment strategy of neuroendocrine tumors].
|
Rev Prat
|
2002
|
0.77
|
|
88
|
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.
|
Neuroendocrinology
|
2017
|
0.76
|
|
89
|
Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results.
|
Clin Endocrinol (Oxf)
|
2006
|
0.76
|
|
90
|
Digestive endocrine tumors.
|
Gastroenterol Clin Biol
|
2006
|
0.76
|
|
91
|
[Imaging strategy for staging and follow-up of endocrine tumors].
|
Bull Cancer
|
2006
|
0.75
|
|
92
|
[Differentiated thyroid cancer in childhood].
|
Bull Cancer
|
2012
|
0.75
|
|
93
|
Chromogranin A as serum marker of pituitary adenomas.
|
Clin Endocrinol (Oxf)
|
2003
|
0.75
|
|
94
|
The lack of antitumor effects of o,p'DDA excludes its role as an active metabolite of mitotane for adrenocortical carcinoma treatment.
|
Horm Cancer
|
2014
|
0.75
|
|
95
|
The clinical spectrum of RET proto-oncogene mutations in codon 790.
|
Eur J Endocrinol
|
2013
|
0.75
|
|
96
|
Follicular cell-derived thyroid cancer in children.
|
Horm Res
|
2005
|
0.75
|
|
97
|
Follicular-cell derived thyroid cancer in children.
|
Eur J Cancer
|
2004
|
0.75
|
|
98
|
Abnormal pelvic uptake on post-therapeutic radioiodine (131I) whole-body scan.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.75
|
|
99
|
Everolimus Effect on Gastrin and Glucagon in Pancreatic Neuroendocrine Tumors.
|
Pancreas
|
2017
|
0.75
|
|
100
|
Hyperandrogenism in a postmenopausal woman presenting with a metastatic ileum endocrine tumor.
|
Fertil Steril
|
2004
|
0.75
|
|
101
|
Natural History of Localized and Locally Advanced Lung atypical Carcinoid after Complete Resection: A Joined French-ITALIAN Multicentric Retrospective Study.
|
Neuroendocrinology
|
2017
|
0.75
|
|
102
|
[Medullary thyroid carcinoma in children].
|
Bull Cancer
|
2013
|
0.75
|
|
103
|
Chemotherapy in Well-Differentiated Pancreatic Neuroendocrine Tumours with Ki-67 ≥10%: Is there a More Effective Antitumor Regimen A Retrospective Multicentric Study of the French Group of Endocrine Tumours (GTE).
|
Neuroendocrinology
|
2017
|
0.75
|
|
104
|
[Clinical cases: a well-differentiated endocrine tumor].
|
Gastroenterol Clin Biol
|
2006
|
0.75
|
|
105
|
Frequency and intensity of pain related to thyroid nodule fine-needle aspiration cytology.
|
Thyroid
|
2013
|
0.75
|
|
106
|
Everolimus Effect on Gastrin and Glucagon in Pancreatic Neuroendocrine Tumors.
|
Pancreas
|
2017
|
0.75
|
|
107
|
[Refractory thyroid cancers].
|
Presse Med
|
2011
|
0.75
|
|
108
|
Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.
|
Ann Surg
|
2017
|
0.75
|
|
109
|
[Angiogenesis and thyroid cancer].
|
Presse Med
|
2009
|
0.75
|
|
110
|
Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy.
|
Endocr Relat Cancer
|
2013
|
0.75
|